연구성과로 돌아가기
2021 연구성과별 연구자 정보 (202 / 2991)
※ 현재 Web of Science 저자 정보만 집계되어 있습니다.
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Document Title | Author Full Name | Author Short Name | Index | Corresponding | Address | ResearcherID | ResearcherID Author Name | ORCID | ORCID Author Name | Related Email |
|---|---|---|---|---|---|---|---|---|---|---|
| ARAF mutations confer resistance to the RAF inhibitor belvarafenib in melanoma | Bae, Inhwan | Bae, I | 9 | Hanmi Pharmaceut Co Ltd, Dept New Chem Ent Discovery, Hanmi Res Ctr, Seoul, South Korea | 0000-0001-5390-2401 | Bae, InHwan | twkimmd@amc.seoul.kr;shivam@gene.com; | |||
| ARAF mutations confer resistance to the RAF inhibitor belvarafenib in melanoma | Dela Cruz, Darlene | Dela Cruz, D | 10 | Genentech Inc, Dept Translat Oncol, San Francisco, CA 94080 USA | twkimmd@amc.seoul.kr;shivam@gene.com; | |||||
| ARAF mutations confer resistance to the RAF inhibitor belvarafenib in melanoma | Hunsaker, Thomas | Hunsaker, T | 11 | Genentech Inc, Dept Translat Oncol, San Francisco, CA 94080 USA | twkimmd@amc.seoul.kr;shivam@gene.com; | |||||
| ARAF mutations confer resistance to the RAF inhibitor belvarafenib in melanoma | Klijn, Christiaan | Klijn, C | 12 | Genentech Inc, Dept Bioinformat, San Francisco, CA 94080 USA | twkimmd@amc.seoul.kr;shivam@gene.com; | |||||
| ARAF mutations confer resistance to the RAF inhibitor belvarafenib in melanoma | Liau, Nicholas P. D. | Liau, NPD | 13 | Genentech Inc, Dept Struct Biol, San Francisco, CA 94080 USA | HJI-9205-2023 | Liau, Nicholas | 0000-0002-3887-899X | Liau, Nicholas | twkimmd@amc.seoul.kr;shivam@gene.com; | |
| ARAF mutations confer resistance to the RAF inhibitor belvarafenib in melanoma | Lin, Eva | Lin, E | 14 | Genentech Inc, Dept Discovery Oncol, San Francisco, CA 94080 USA | twkimmd@amc.seoul.kr;shivam@gene.com; | |||||
| ARAF mutations confer resistance to the RAF inhibitor belvarafenib in melanoma | Martin, Scott E. | Martin, SE | 15 | Genentech Inc, Dept Discovery Oncol, San Francisco, CA 94080 USA | twkimmd@amc.seoul.kr;shivam@gene.com; | |||||
| ARAF mutations confer resistance to the RAF inhibitor belvarafenib in melanoma | Modrusan, Zora | Modrusan, Z | 16 | Genentech Inc, Dept Microchem Prote & Lipid, San Francisco, CA 94080 USA | twkimmd@amc.seoul.kr;shivam@gene.com; | |||||
| ARAF mutations confer resistance to the RAF inhibitor belvarafenib in melanoma | Piskol, Robert | Piskol, R | 17 | Genentech Inc, Dept Bioinformat, San Francisco, CA 94080 USA | twkimmd@amc.seoul.kr;shivam@gene.com; | |||||
| ARAF mutations confer resistance to the RAF inhibitor belvarafenib in melanoma | Segal, Ehud | Segal, E | 18 | Genentech Inc, Dept Translat Oncol, San Francisco, CA 94080 USA | twkimmd@amc.seoul.kr;shivam@gene.com; | |||||
| ARAF mutations confer resistance to the RAF inhibitor belvarafenib in melanoma | Venkatanarayan, Avinashnarayan | Venkatanarayan, A | 19 | Genentech Inc, Dept Discovery Oncol, San Francisco, CA 94080 USA | twkimmd@amc.seoul.kr;shivam@gene.com; | |||||
| ARAF mutations confer resistance to the RAF inhibitor belvarafenib in melanoma | Ye, Xin | Ye, X | 20 | Genentech Inc, Dept Discovery Oncol, San Francisco, CA 94080 USA | twkimmd@amc.seoul.kr;shivam@gene.com; | |||||
| ARAF mutations confer resistance to the RAF inhibitor belvarafenib in melanoma | Yin, Jianping | Yin, JP | 21 | Genentech Inc, Dept Struct Biol, San Francisco, CA 94080 USA | twkimmd@amc.seoul.kr;shivam@gene.com; | |||||
| ARAF mutations confer resistance to the RAF inhibitor belvarafenib in melanoma | Zhang, Liangxuan | Zhang, LX | 22 | Genentech Inc, Dept Oncol Biomarker Dev, San Francisco, CA 94080 USA | twkimmd@amc.seoul.kr;shivam@gene.com; | |||||
| ARAF mutations confer resistance to the RAF inhibitor belvarafenib in melanoma | Kim, Jin-Soo | Kim, JS | 23 | Seoul Natl Univ, Dept Internal Med, Boramae Med Ctr, Seoul, South Korea | AGF-2385-2022 | Kim, In-Ryoung | twkimmd@amc.seoul.kr;shivam@gene.com; |
페이지 이동: